Cushing Syndrome II: Pathophysiology
Autoimmune Disorders
Cushing Syndrome I: Introduction
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Asthma: Pathogenesis and Management
Hypothalamic-Pituitary Axis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 14, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
E Meimaridou1, C R Hughes, J Kowalczyk
1Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Familial glucocorticoid deficiency (FGD) is caused by new gene defects in MCM4 and NNT. These findings reveal novel genetic mechanisms underlying ACTH resistance and adrenal cortex stress sensitivity.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: